These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 31138337)

  • 1. The Dobson-Rawlins pact and the National Institute for Health and Care Excellence: impact of political independence on scientific and legal accountability.
    McPherson S; Sunkin M
    Br J Psychiatry; 2020 Apr; 216(4):231-234. PubMed ID: 31138337
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safeguarding children's rights in psychopharmacological research: ethical and legal issues.
    Kölch M; Ludolph AG; Plener PL; Fangerau H; Vitiello B; Fegert JM
    Curr Pharm Des; 2010; 16(22):2398-406. PubMed ID: 20513231
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The NICE way of influencing health spending: a conversation with Sir Michael Rawlins. Interview by Nicholas Timmins.
    Rawlins M
    Health Aff (Millwood); 2009; 28(5):1360-5. PubMed ID: 19743561
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The process of producing a "NICE" guideline.
    Goldberg D
    Epidemiol Psichiatr Soc; 2010; 19(3):211-3. PubMed ID: 21261216
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Procedures and methods of benefit assessments for medicines in Germany].
    Bekkering GE; Kleijnen J
    Dtsch Med Wochenschr; 2008 Dec; 133 Suppl 7():S225-46. PubMed ID: 19034813
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Commercial Influence on Political Declarations: The Crucial Distinction Between Consultation and Negotiation and the Need for Transparency in Lobbying Comment on "Competing Frames in Global Health Governance: An Analysis of Stakeholder Influence on the Political Declaration on Non-communicable Diseases".
    Berner-Rodoreda A; Jahn A
    Int J Health Policy Manag; 2022 Jul; 11(7):1219-1221. PubMed ID: 34634870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuroscience in the Courtroom: From responsibility to dangerousness, ethical issues raised by the new French law].
    Gkotsi GM; Moulin V; Gasser J
    Encephale; 2015 Oct; 41(5):385-93. PubMed ID: 25439859
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Psychopharmacology news.
    Silva RR
    J Child Adolesc Psychopharmacol; 2004; 14(1):1-2. PubMed ID: 15142384
    [No Abstract]   [Full Text] [Related]  

  • 10. Law, ethics and professional guidelines in medical research.
    Lötjönen S
    Med Law; 2004; 23(3):657-64. PubMed ID: 15532955
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The Impact of NICE Guidance on UK Psychiatry].
    Kissane LA; Tamura N; Yoshimura K
    Seishin Shinkeigaku Zasshi; 2017; 119(3):166-172. PubMed ID: 30620851
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulatory and Ethical Issues in Pediatric Clinical Research: Recommendations From a Panel Discussion.
    Kshirsagar N; Swaminathan S; Jog P; Dalwai S; Mathur R; Shekhar C; Meibohm B; Gupta YK; Shafiq N; Sunkara G; Somani VG; Kulkarni P; Tseng B; Mehta D
    J Clin Pharmacol; 2017 Aug; 57(8):943-946. PubMed ID: 28513861
    [No Abstract]   [Full Text] [Related]  

  • 13. Publication ethics - What do we need to know?
    Mills M
    J Appl Clin Med Phys; 2019 Apr; 20(4):4-5. PubMed ID: 30892781
    [No Abstract]   [Full Text] [Related]  

  • 14. Professor Sir Michael Rawlins--chairman of NICE. National Institute of Clinical Excellence. Interviewed by Sue Silver.
    Rawlins M
    Lancet Oncol; 2000 Oct; 1():113-7. PubMed ID: 11905663
    [No Abstract]   [Full Text] [Related]  

  • 15. The accountability problem of the National Institute for Health and Clinical Excellence.
    Hasman A
    Med Law; 2008 Mar; 27(1):83-93. PubMed ID: 18592883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Local health governance in Tajikistan: accountability and power relations at the district level.
    Jacobs E; Baez Camargo C
    Int J Equity Health; 2020 Mar; 19(1):30. PubMed ID: 32122333
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ethics and governance of medical research: what does regulation have to do with morality?
    Ashcroft RE
    New Rev Bioeth; 2003 Nov; 1(1):41-58. PubMed ID: 15706668
    [No Abstract]   [Full Text] [Related]  

  • 18. NICE, but will they help people with depression? The new National Institute for Clinical Excellence depression guidelines.
    Whitty P; Gilbody S
    Br J Psychiatry; 2005 Mar; 186():177-8. PubMed ID: 15738494
    [No Abstract]   [Full Text] [Related]  

  • 19. Editorial: genetic and genomic research-changing patterns of accountability.
    Lunshof JE; Chadwick R
    Account Res; 2011 May; 18(3):121-31. PubMed ID: 21574069
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Exempting low-risk health and medical research from ethics reviews: comparing Australia, the United Kingdom, the United States and the Netherlands.
    Scott AM; Kolstoe S; Ploem MCC; Hammatt Z; Glasziou P
    Health Res Policy Syst; 2020 Jan; 18(1):11. PubMed ID: 31992320
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.